Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.
about
Herbal medicines for the treatment of inflammatory bowel diseaseBotanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewProbiotics in inflammatory bowel diseases and associated conditionsUse of complementary and alternative medicine: a survey in Turkish gastroenterology patients.Terpenes from Forests and Human HealthPerilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study.Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures.Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical studyEffect of Boswellia papyrifera on cognitive impairment in multiple sclerosis.Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicineReported effects of non-traditional treatments and complementary and alternative medicine by retinitis pigmentosa patients.Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel diseaseA double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee.Herbal Medicine in Primary Healthcare in Germany: The Patient's Perspective.A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current EvidenceA review of complementary and alternative approaches to immunomodulation.Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.Integrative medicine in gastrointestinal disease: evaluating the evidence.Boswellic acids: a group of medicinally important compounds.Factors associated with the use of probiotics in patients with inflammatory bowel disease.Use of complementary and alternative medicine by patients with inflammatory bowel disease.Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.What attitudes and needs do citizens in Europe have in relation to complementary and alternative medicine?Ulcerative proctitis: an update on the pharmacotherapy and management.Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun.Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.Use of complementary medicinal therapies in West Pomerania: a population-based study.Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications.Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease
P2860
Q24194984-049157C4-99E2-443C-8A84-EC2B970E1509Q26998841-36BB88D0-1F6B-4E2B-87B0-D5A4EDF95D66Q27002496-A09E4E24-03F8-4F37-BD68-C217922F77D4Q33512608-21C7DEED-9167-4B22-9758-B01C12E9522EQ33596266-D6008EC9-0DAD-424D-A3F3-E26D00C37CECQ33687137-3498030F-54AA-46B3-BFFB-F839676354D2Q34191499-EF589FE0-7490-4BB9-9E20-7503AC7C8F9AQ34240527-FC4C7921-45D2-43F2-9AF0-0FE9609E4E07Q34280379-22600EB5-5599-4673-89D2-A42C1BBC8329Q34558974-81DBFEE8-8F92-4826-856B-D9A5665C5472Q35064501-A07F0E1D-E8A1-4FED-A4EB-C316A082F8DBQ35163771-7D2D2E9C-E171-4997-9CD5-B68402EC1EC3Q35221841-E866C588-2E87-4319-9339-2E1287385240Q35407746-628EB2CE-A4C2-4248-B4FF-A75B1A6196E0Q36546672-84B7C847-5F5C-4C72-80D2-7E3782C40B79Q36955387-3FE10E7F-1250-42F3-89BC-9C1270C4943EQ37055823-451C204A-E1BE-45C1-978F-ECC39E454A2DQ37060108-7A099460-AE30-4836-92B1-448EC82D8114Q37312768-426F4E35-930A-4110-9811-A7FEF0C0CD90Q37345889-FE64A209-7BBF-4DDE-8F1F-6A92E29DD785Q37448772-6C6C62AC-F14E-4BC9-BB12-FD703D14CD5EQ37513642-707B28F8-707B-4F65-8E69-0ED56EF517F2Q37789695-47A75049-0695-44AE-9BA3-600FC130BE71Q37992245-4B75B675-18EF-4E7B-9B4A-D29C3EC9EA66Q38083493-E1869CE6-E072-4E28-81DF-B4436975A818Q38123930-754B2C22-56E0-4F68-94F2-C530BDBF4F5CQ38212456-2F8EB13F-B221-4CAC-ADC0-C0DA9B88800FQ40100857-18288004-D34D-4E5E-AEC1-410BE8F7C8D1Q42158376-91085620-D7AE-4F21-99D3-31FC868AA71FQ43691054-B6C909E7-371D-4CF4-A799-04D68C49EB71Q46850181-7FC5FB8C-7FB9-4336-94C2-174AC595F833Q50984764-CCB458E7-80EB-4735-8B02-413EE2184F5FQ55347286-080140DD-B803-4600-ABFB-4B155BE94DA9Q56638525-A9BCB817-D8A6-4F7E-8E4E-E9EC292874E1
P2860
Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Use of complementary and alter ...... th inflammatory bowel disease.
@ast
Use of complementary and alter ...... th inflammatory bowel disease.
@en
type
label
Use of complementary and alter ...... th inflammatory bowel disease.
@ast
Use of complementary and alter ...... th inflammatory bowel disease.
@en
prefLabel
Use of complementary and alter ...... th inflammatory bowel disease.
@ast
Use of complementary and alter ...... th inflammatory bowel disease.
@en
P2093
P2860
P50
P356
P1476
Use of complementary and alter ...... th inflammatory bowel disease.
@en
P2093
Benno Brinkhaus
Eckhart G Hahn
Stefan N Willich
P2860
P2888
P356
10.1186/1472-6882-6-19
P577
2006-05-22T00:00:00Z
P5875
P6179
1049268342